Pediatric Formulas: An Update

Aamer Imdad1, Rida Sherwani2, Kellie Wall3

  • 1Division of Gastroenterology, Hepatology, Pancreatology, and Nutrition, Department of Pediatrics, Stead Family Children's Hospital, University of Iowa, Iowa City, IA.

Pediatrics in Review
|June 30, 2024
PubMed

Insights

US families sought alternatives during infant formula shortages. European formulas, while often adequate, differ in composition and preparation from US standards, requiring careful pediatrician and family awareness.

Area of Science:

  • Nutritional Science
  • Pediatric Nutrition
  • Food Regulation

Background:

  • US experienced infant formula shortages due to supply chain disruptions and contamination.
  • Families sought alternative formulas, including imported European options.
  • Differences exist between US and European infant formulas.

Purpose of the Study:

  • To inform pediatricians and families about differences between US and European infant formulas.
  • To guide the appropriate use and preparation of imported formulas.
  • To highlight considerations for specialized pediatric formulas.

Main Methods:

  • Comparative analysis of European and US infant formula regulations and composition.
  • Review of nutritional adequacy and preparation guidelines for various formula types.
  • Examination of pediatric formula categories and non-formula milk alternatives.

Main Results:

  • European infant formulas vary from US-regulated ones in primary source, age appropriateness, mixing, labeling, and nutrient content.
  • Most European formulas are nutritionally adequate but require informed use.
  • Pediatric formulas (polymeric, hydrolyzed, elemental, blenderized) and plant-based drinks show significant compositional variability and may not be nutritionally complete.

Conclusions:

  • Pediatricians and families must understand European formula differences for safe infant feeding.
  • Older infant formulas and non-formula milk drinks are not suitable for children requiring specialized liquid nutrition.
  • FDA regulation of pediatric formulas beyond infant stage is limited, necessitating careful product selection.